Dr. Yelena Krupitskaya, MD

Dr. Krupitskaya practices at Concord Medical Center in Concord, California, part of John Muir Health.

Dr. Krupitskaya's NPI, 1750565529, was assigned on December 28, 2007. Dr. Krupitskaya graduated from Albert Einstein College of Medicine of Yeshiva University in 2003. Dr. Krupitskaya holds California license A95966.

Dr. Krupitskaya's primary practice is Concord Medical Center, at 2540 East St, Concord, CA 94520 in Contra Costa County. The practice phone is (925) 682-8200.

Dr. Krupitskaya's primary practice is Concord Medical Center in Concord, California, part of John Muir Health. Dr. Krupitskaya is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is John Muir Health. Dmand AI also links Dr. Krupitskaya to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krupitskaya practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Krupitskaya's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Krupitskaya is licensed in California.

CMS data shows 3,144 Medicare services from Dr. Krupitskaya across 18 procedure codes in 2024, for 391 Medicare patients. Medicare paid $158,549 for them.

CMS counts 391 Medicare patients who saw Dr. Krupitskaya in 2024. The largest group is 75 to 84, with 144 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 25% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Krupitskaya's median patient age at 71, with 66% women.

In 2024, Dr. Krupitskaya wrote 703 Medicare Part D claims for 148 patients. 66% of them were for generic drugs. CMS names the drug for 394 of them, across 17 drugs with 11 or more claims each, at $489,269 in total drug cost. In 2023, CMS named 161 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Krupitskaya for performance year 2024, reported as part of a group. Dr. Krupitskaya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Krupitskaya as offering telehealth.

Dmand AI links 4 papers to Dr. Krupitskaya, published from 2011 to 2012. 2012 was the busiest year, with 2. Dr. Krupitskaya's most frequent co-authors are Heather Ann Wakelee, MD, Alexander Dimitrios Colevas, MD and Kristen Nooshin Ganjoo, MD.

CMS Open Payments shows 711 general payments to Dr. Krupitskaya from 75 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Bristol-Myers Squibb Company paid the most, $1,287.

Dr. Krupitskaya graduated from Albert Einstein College of Medicine of Yeshiva University in 2003.